Sigma BioBlogs

In the most recent print edition of Biowire, we interviewed Dr. Hakim Djaballah at the Memorial Sloan-Kettering Cancer Center.

His high throughput screening laboratory provides both chemical and RNAi screening services and is helping oncology clinicians and basic researchers to harness the power of high throughput screening technologies towards a better understanding of signaling pathways in cancer cells and discovering novel drugs to treat cancer.

Dr. Hakim Djaballah in the lab

As a result they are developing new clinical strategies, and furthering the understanding of various types of cancer.

Here is a sampling of Dr. Djaballah’s collaborative publications.

Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors.

High-throughput identification of inhibitors of human mitochondrial peptide deformylase.

Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.

Get the full list.

We look forward to hearing more about the successes of the Dr. Djaballah and his collaborators!  Subscribe to Biowire to stay informed of news from Sigma Life Science and the researchers we serve.